inquiry
Leave Your Message

Noopept GVS-111 Nootropic Peptide 157115-85-0 - High Purity Powder from China Suppliers & Factory

,

Product Name: Noopept

,

CAS: 157115-85-0

,

MF: C17H22N2O4

,

MW: 318.37

,

EINECS: 1592732-453-0

,

Appearance: Fine powder

,

Purity: ≥98%

,

Packaging: Available in 1kg, 5kg, 10kg, 50kg, and 100kg (custom packaging options also available)

,

Origin: China

,

As a leading supplier and factory of Noopept in China, we ensure high-quality standards and exceptional purity levels of our products. Noopept is widely recognized for its cognitive enhancing properties and is available in various quantities to meet your needs. Trust our reliable manufacturing and sourcing capabilities to provide you with the best Noopept for your requirements.

,

    Brief Introduction

    Noopept is a well-known nootropic that is often suggested as a first nootropic. Noopept is over 500 times more potent than Piracetam. Like piracetam, it is capable of enhancing memory, learning, and focus. Noopept is also a powerful antioxidant that prevents neurological disorders and helps the brain grow. Because of this, it is thought to improve long-term memory. The human studies have shown promising results, with potential application in the treatment of Alzheimer's disease.
    Noopept (development codes: GVS-111, SGS-111; INN: Omberacetam) is a proline-containing synthetic dipeptide developed by the Russian Academy of Sciences using an original approach based on the imitation of a nonpeptide nootrope (piracetam) structure by means of short-peptide design. It is approved in Russia as a cognition enhancer and differs structurally from classic racetams, belonging to the dipeptide class of nootropics with dual nootropic and neuroprotective effects.
    Key Scientific Value & Findings

    Ultra-High Potency

    1000-fold Stronger than Piracetam: Experimental studies show that Noopept exceeds piracetam by 1000 times in effective dose level. In contrast to piracetam facilitating only the early stages of the memory process, Noopept positively influences the memory consolidation and retrieval steps as well. Additionally, Noopept produces an additional selective anxiolytic action.

    Unique Neuroprotective Mechanism

    Noopept demonstrates pronounced neuroprotective effects confirmed both in vivo (in various forms of brain ischemia) and in vitro (on various neuronal models). Its action is based on:

    • Antioxidant effect
    • Anti-inflammatory action
    • Ability to inhibit neurotoxicity of excess calcium and glutamate
    • Improvement of blood rheology

    α7 Nicotinic Acetylcholine Receptor Modulation

    A 2022 study found that Noopept (5 µM) increases action potential firing frequency recorded from GABAergic interneurons in the stratum radiatum of hippocampal CA1 region. This effect was almost completely abolished by α7 nAChR-selective antagonists (α-bungarotoxin and methyllycaconitine), indicating that α7 nAChRs are an important site of action of Noopept.

    HIF-1 Signaling Pathway Activation

    Research indicates that Noopept is a moderate activator of the HIF-1 signaling pathway, acting through HIF-1 stabilization, likely by inducing HIF-1α transcription and translation, resulting in increased HIF-dependent gene expression. This mechanism may contribute to its neurotropic activity.

    Alzheimer's Disease Research Potential

    • In an Alzheimer's disease model induced by β-amyloid (25-35) injection into Meynert basal nuclei, Noopept (0.5 mg/kg, preventive intraperitoneal injections) completely prevented mnestic disorders.
    • Even when treatment was started 15 days after injury (when neurodegenerative changes were still acutely pronounced), Noopept exhibited a significant normalizing effect.
    • Mechanisms include: choline-positive effect, multicomponent neuroprotective effect, stimulation of antibody production to β-amyloid.

    Oral Bioavailability Advantage

    It was established for the first time that the activity of Noopept is retained both upon parenteral introduction and upon peroral administration, which is a principal advantage of this proline-containing dipeptide over other, more complex peptides. This property provided a basis for the development of oral formulations.

    Our Supply & Service Advantages

    Frequently Asked Questions

    How does Noopept compare to Piracetam in terms of potency?

    Noopept is over 500 to 1000 times more potent than Piracetam. Unlike piracetam, which only facilitates the early stages of memory, Noopept positively influences memory consolidation and retrieval steps, while also producing an additional selective anxiolytic (anti-anxiety) effect.

    What are the primary neuroprotective mechanisms of Noopept?

    Noopept's neuroprotective action is based on its antioxidant effect, anti-inflammatory action, ability to inhibit the neurotoxicity of excess calcium and glutamate, and the improvement of blood rheology.

    What is the significance of the α7 Nicotinic Acetylcholine Receptor in Noopept's function?

    Research indicates that Noopept increases action potential firing frequency in GABAergic interneurons of the hippocampal CA1 region. This effect is mediated by α7 nicotinic acetylcholine receptors (nAChRs), making them an important site of action for Noopept.

    How does Noopept support research in Alzheimer's disease?

    In Alzheimer's models, Noopept has been shown to prevent mnestic (memory) disorders, even when administered 15 days after injury when neurodegenerative changes are pronounced. Its mechanisms include a choline-positive effect, multicomponent neuroprotection, and the stimulation of antibody production to β-amyloid.

    What is the bioavailability advantage of Noopept?

    Unlike other complex peptides, Noopept retains its biological activity when administered both parenterally and perorally (orally). This oral bioavailability is a major advantage of this proline-containing dipeptide, allowing for the development of oral formulations.

    Leave Your Message